Literature DB >> 24363861

Priapism: current updates in clinical management.

Phil Hyun Song1, Ki Hak Moon1.   

Abstract

Priapism is a persistent penile erection that continues for hours beyond, or is unrelated to, sexual stimulation. Priapism requires a prompt evaluation and usually requires an emergency management. There are two types of priapism: 1) ischemic (veno-occlusive or low-flow), which is found in 95% of cases, and 2) nonischemic (arterial or high-flow). Stuttering (intermittent or recurrent) priapism is a recurrent form of ischemic priapism. To initiate appropriate management, the physician must decide whether the priapism is ischemic or nonischemic. In the management of an ischemic priapism, resolution should be achieved as promptly as possible. Initial treatment is therapeutic aspiration with or without irrigation of the corpora. If this fails, intracavernous injection of sympathomimetic agents is the next step. Surgical shunts should be performed in cases involving failure of nonsurgical treatment. The first management of a nonischemic priapism should be observation. Selective arterial embolization is recommended for the management of nonischemic priapism in cases that request treatment. The goal of management for stuttering priapism is prevention of future episodes. This article provides a review of recent clinical developments in the medical and surgical management of priapism and an investigation of scientific research activity in this rapidly developing field of study.

Entities:  

Keywords:  Erectile dysfunction; Priapism; Surgery

Year:  2013        PMID: 24363861      PMCID: PMC3866283          DOI: 10.4111/kju.2013.54.12.816

Source DB:  PubMed          Journal:  Korean J Urol        ISSN: 2005-6737


  40 in total

1.  Intracavernosal phenylephrine for recurrent priapism: self-administration by drug delivery implant.

Authors:  D J Ralph; E S Pescatori; G S Brindley; J P Pryor
Journal:  J Urol       Date:  2001-05       Impact factor: 7.450

Review 2.  The aetiology, pathogenesis and management of priapism.

Authors:  S R Keoghane; M E Sullivan; M A W Miller
Journal:  BJU Int       Date:  2002-07       Impact factor: 5.588

3.  VENOUS BYPASS TO CONTROL PRIAPISM.

Authors:  J T GRAYHACK; W MCCULLOUGH; V J O'CONOR; O TRIPPEL
Journal:  Invest Urol       Date:  1964-03

4.  Juvenile posttraumatic high-flow priapism: current management dilemmas.

Authors:  Jeffrey B Marotte; James D Brooks; Daniel Sze; William A Kennedy
Journal:  J Pediatr Surg       Date:  2005-04       Impact factor: 2.545

5.  The use of high-resolution magnetic resonance imaging in the management of patients presenting with priapism.

Authors:  David J Ralph; Nigel C Borley; Clare Allen; Alex Kirkham; Alex Freeman; Suks Minhas; Asif Muneer
Journal:  BJU Int       Date:  2010-12       Impact factor: 5.588

6.  Cavernospongiosum shunt in the treatment of priapism.

Authors:  E C Sacher; E Sayegh; F Frensilli; P Crum; R Akers
Journal:  J Urol       Date:  1972-07       Impact factor: 7.450

7.  T-shaped shunt and intracavernous tunneling for prolonged ischemic priapism.

Authors:  William O Brant; Maurice M Garcia; Anthony J Bella; Tom Chi; Tom F Lue
Journal:  J Urol       Date:  2009-02-23       Impact factor: 7.450

8.  Is the combination of superselective transcatheter autologous clot embolization and duplex sonography-guided compression therapy useful treatment option for the patients with high-flow priapism?

Authors:  M Cakan; U Altu Gcaron; M Aldemir
Journal:  Int J Impot Res       Date:  2006 Mar-Apr       Impact factor: 2.896

9.  The immediate insertion of a penile prosthesis for acute ischaemic priapism.

Authors:  David J Ralph; Giulio Garaffa; Asif Muneer; Alex Freeman; Rowland Rees; Andrew N Christopher; Sukbinder Minhas
Journal:  Eur Urol       Date:  2008-10-01       Impact factor: 20.096

10.  Investigating the effects of high-dose phenylephrine in the management of prolonged ischaemic priapism.

Authors:  Asif Muneer; Suks Minhas; Alex Freeman; Pardeep Kumar; David J Ralph
Journal:  J Sex Med       Date:  2008-05-07       Impact factor: 3.802

View more
  9 in total

Review 1.  Molecular pathophysiology of priapism: emerging targets.

Authors:  Uzoma A Anele; Belinda F Morrison; Arthur L Burnett
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

2.  How I treat priapism.

Authors:  Uzoma A Anele; Brian V Le; Linda M S Resar; Arthur L Burnett
Journal:  Blood       Date:  2015-03-25       Impact factor: 22.113

3.  Priapism after tumor necrosis factor alpha inhibitor use.

Authors:  Adam J Kreitenberg; Elizabeth C Ortiz; Daniel G Arkfeld
Journal:  Clin Rheumatol       Date:  2015-01-13       Impact factor: 2.980

4.  Coronavirus disease 2019 (COVID-19) and priapism: An unexplored association.

Authors:  Dominic Mpumelelo Malinga; Abdullah E Laher; Jared McDowall; Ahmed Adam
Journal:  Curr Urol       Date:  2022-06-27

5.  Ischemic priapism: Can eosinophil count and platelet functions be positive predictive factors in etiopathogenesis.

Authors:  Mehmet Giray Sönmez; Cengiz Kara; Adnan Karaibrahimoğlu; Leyla Öztürk Sönmez; Yunus Emre Göğer; Mehmet Balasar; Hakki Hakan Taşkapu; Mehmet Mesut Pişkin; Ahmet Öztürk; Mehmet Kilinç
Journal:  Can Urol Assoc J       Date:  2017-07-11       Impact factor: 1.862

Review 6.  Clinical Management of Priapism: A Review.

Authors:  Kazuyoshi Shigehara; Mikio Namiki
Journal:  World J Mens Health       Date:  2016-04-30       Impact factor: 5.400

7.  Superselective embolization for high-flow priapism refractory to medical and surgical treatments.

Authors:  Yonghua Bi; Mengfei Yi; Zepeng Yu; Xinwei Han; Jianzhuang Ren
Journal:  BMC Urol       Date:  2020-06-30       Impact factor: 2.264

8.  A novel approach to treatment of priapism refractory to non-surgical methods: A single-case experience.

Authors:  Nassib Abou Heidar; Jad A Degheili; Gerges Bustros; Wassim Wazzan; Muhammad Bulbul
Journal:  Arab J Urol       Date:  2019-06-12

9.  Presumptive Non-Ischemic Priapism in a Cat.

Authors:  Jeong-Min Lee; Ah-Won Sung; Han-Joon Lee; Joong-Hyun Song; Kun-Ho Song
Journal:  Vet Sci       Date:  2022-01-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.